Tag: Justin

Heffernan Insurance Brokers Acquires Pac Global Insurance Brokerage, Inc.

WALNUT CREEK, Calif., July 22, 2025 /PRNewswire/ -- Heffernan Insurance Brokers, one of the largest full-service, independent insurance brokerage firms in the United States,...

Form 8.5 (EPT/RI) – Greencore Group Plc

FORM 8.5 (EPT/RI)

IDEAYA Biosciences to Participate in Upcoming July 2025 Investor Relations Event

SOUTH SAN FRANCISCO, Calif., July 21, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and...

EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)

EURneffy (neffy^® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions

Beijing Review: Chinese and U.S. youth explore the charm of Beijing’s history and modernity

BEIJING, July 16, 2025 /PRNewswire/ -- On July 7-12, 25 young delegates from China and the United States gathered in Beijing for the Across...

SIGMA AI Closes on Investment from Trading Technologies to Build TT AI and Innovation Hub

London, July 15, 2025 (GLOBE NEWSWIRE) -- SIGMA AI, an innovative fintech company specialising in real-time data and AI-driven insights, today announced a minority investment by Trading Technologies, International Inc. (TT), a global capital markets technology platform services provider.

8AM Golf Sells GolfLogix to Revelyst, Owners of Foresight Sports and Bushnell Golf

After years of fostering Golflogix's growth and development, 8AM Golf sells the top-rated golf GPS app to the premier designer and manufacturer of precision...

Music Licensing, Inc. and Pro Music Rights Featured in Bloomberg News and Los Angeles Times Amid Industry Spotlight on Licensing Fees

NAPLES, FL, July 14, 2025 (GLOBE NEWSWIRE) -- Music Licensing, Inc. (OTC: SONG) and its wholly owned subsidiary, Pro Music Rights, were recently featured in Bloomberg News and the Los Angeles Times in connection with national coverage on the rising costs and growing complexity of music licensing for restaurants and bars. The coverage highlights Pro Music Rights as a leading innovator among performance rights organizations (PROs), positioned to modernize an industry long dominated by legacy structures.

June in Review: 14 Top Health Press Releases

A roundup of the most newsworthy healthcare press releases from PR Newswire, including a nasal spray for sleep apnea, a landmark study in clinical...

Make-A-Wish and ESPN team up for the 18th season of the “My Wish” series

Since 2006, the summer series has showcased more than 80 inspiring stories of wish kids meeting their favorite teams and athletes PHOENIX, July 10, 2025...

Justin Mateen, Tyler Mateen and Cayton Family Acquire Historic El Encanto Hotel

Justin Mateen and Tyler Mateen, in partnership with the Cayton family’s Culver Capital, have acquired the legendary El Encanto Hotel in Santa Barbara.

Verizon donates $100,000 to support Texas Search and Rescue and waives call/text/data usage for hardest hit customers

What you need to know:

SafeSpace Global Corporation welcomes Katie Piperata as its Vice President of Senior Living

Senior Living Leader Brings Full-Spectrum Industry Experience to Guide AI Transformation Across the Sector

Clarification on Hivello Buy-Back Announcement

LONDON and AMSTERDAM, July 04, 2025 (GLOBE NEWSWIRE) -- Blockmate Ventures Inc. (TSX.V: MATE) (OTCQB: MATEF) (FSE: 8MH1) (“Blockmate” or the “Company”) announces a clarification following the recent news regarding the buy-back of 13.5 million $HVLO tokens under the Hivello Buy & Burn initiative.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsJustin

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress